This Viewpoint describes dose optimization and pragmatic de-escalation for financially constrained health systems.
No takes yet. Share an insight, caveat, or question.
Daniel Vilarim Araújo (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: